SL550137 |
HCT116/KRAS_G13C/G13C homozygote, single clone, 2×10^6 cells |
1 vial |
Detail
|
Inquire |
SL550141 |
EGFR T790M Heterozygous HCT116 Cancer Biomarker Mutant Cell Line, 2×10^6 cells |
1 vial |
Detail
|
Inquire |
SL550143 |
EGFR T790M C797S Homozygous HCT116 Cancer Biomarker Mutant Cell Line, 2×10^6 cells |
1 vial |
Detail
|
Inquire |
SL550146 |
AKT1 E17K Heterozygous HCT116 Cancer Biomarker Mutant Cell Line, 2×10^6 cells |
1 vial |
Detail
|
Inquire |
SL550154 |
NRAS Q61K Heterozygous HCT116 Cancer Biomarker Mutant Cell Line, 2×10^6 cells |
1 vial |
Detail
|
Inquire |
SL550147 |
KRAS G13D Homozygous HCT116 Cancer Biomarker Mutant Cell Line, 2×10^6 cells |
1 vial |
Detail
|
Inquire |
SL550153 |
KRAS G12D Heterozygous HCT116 Cancer Biomarker Mutant Cell Line, 2×10^6 cells |
1 vial |
Detail
|
Inquire |
SL550158 |
KRAS G12C Homozygous HCT116 Cancer Biomarker Mutant Cell Line, 2×10^6 cells |
1 vial |
Detail
|
Inquire |
SL550166 |
KRAS G13C/G13D Heterozygous HCT116 Cancer Biomarker Mutant Cell Line, 2×10^6 cells |
1 vial |
Detail
|
Inquire |
SL550151 |
EGFR T790M C797S Heterozygous HCT116 Cancer Biomarker Mutant Cell Line, 2×10^6 cells |
1 vial |
Detail
|
Inquire |
SL550155 |
NRAS G12D Heterozygous HCT116 Cancer Biomarker Mutant Cell Line, 2×10^6 cells |
1 vial |
Detail
|
Inquire |
SL550157 |
EGFR C797S Heterozygous RKO Cancer Biomarker Mutant Cell Line, 2×10^6 cells |
1 vial |
Detail
|
Inquire |
SL550160 |
KRAS G13C Homozygous HCT116 Cancer Biomarker Mutant Cell Line, 2×10^6 cells |
1 vial |
Detail
|
Inquire |
SL550161 |
KRAS G13C/G13G Heterozygous HCT116 Cancer Biomarker Mutant Cell Line, 2×10^6 cells |
1 vial |
Detail
|
Inquire |
SL550156 |
EGFR C797S Homozygous RKO Cancer Biomarker Mutant Cell Line, 2×10^6 cells |
1 vial |
Detail
|
Inquire |
SL550167 |
EGFR S768I Homozygous HCT116 Cancer Biomarker Mutant Cell Line, 2×10^6 cells |
1 vial |
Detail
|
Inquire |
SL550175 |
HEK293 stably expressing dCas9-KRAB, 2×10^6 cells |
1 vial |
Detail
|
Inquire |
SL550180 |
HEK293T cells stably expressing human ACE2 (NM_021804.2), 2×10^6 cells |
1 vial |
Detail
|
Inquire |
SL550169 |
EGFR L861Q Heterozygous HCT116 Cancer Biomarker Mutant Cell Line, 2×10^6 cells |
1 vial |
Detail
|
Inquire |
SL550172 |
Human cell line RKO (colon carcinoma), 2×10^6 cells |
1 vial |
Detail
|
Inquire |
SL550173 |
HEK293 stably expressing dCas9-VP64 and MPH complex, 2×10^6 cells |
1 vial |
Detail
|
Inquire |
SL550178 |
A549 stably expressing dCas9-VP64 and MPH complex, 2x106 cells, 2×10^6 cells |
1 vial |
Detail
|
Inquire |
SL550162 |
EGFR T790M Homozygous RKO Cancer Biomarker Mutant Cell Line, 2×10^6 cells |
1 vial |
Detail
|
Inquire |
SL550163 |
EGFR T790M Heterozygous RKO Cancer Biomarker Mutant Cell Line, 2×10^6 cells |
1 vial |
Detail
|
Inquire |
SL550164 |
EGFR T790M C797S Homozygous RKO Cancer Biomarker Mutant Cell Line, 2×10^6 cells |
1 vial |
Detail
|
Inquire |
SL550165 |
EGFR T790M C797S Heterozygous RKO Cancer Biomarker Mutant Cell Line, 2×10^6 cells |
1 vial |
Detail
|
Inquire |
SL550168 |
EGFR L861Q Homozygous HCT116 Cancer Biomarker Mutant Cell Line, 2×10^6 cells |
1 vial |
Detail
|
Inquire |
SL550170 |
EGFR V769D770insASV Homozygous HCT116 Cancer Biomarker Mutant Cell Line, 2×10^6 cells |
1 vial |
Detail
|
Inquire |
SL550171 |
Human cell line HCT116 (colorectal carcinoma), 2×10^6 cells |
1 vial |
Detail
|
Inquire |
SL550174 |
MCF7 stably expressing dCas9-VP64 and MPH complex, 2×10^6 cells |
1 vial |
Detail
|
Inquire |
SL550177 |
HeLa stably expressing dCas9-VP64 and MPH complex, 2x106 cells, 2×10^6 cells |
1 vial |
Detail
|
Inquire |
SL550176 |
HeLa stably expressing dCas9-KRAB, 2×10^6 cells |
1 vial |
Detail
|
Inquire |
SL550179 |
K562 stably expressing dCas9-VP64 and MPH complex, 2x106 cells, 2×10^6 cells |
1 vial |
Detail
|
Inquire |
SL550184 |
Human carotid artery-derived smooth muscle cell line stably expressing SV40 large T antigen, 2×10^6 cells |
1 vial |
Detail
|
Inquire |
SL550192 |
NIH-3T3 mouse embryo fibroblast cell line dual-labeled with luciferase and GFP, 2×10^6 cells |
1 vial |
Detail
|
Inquire |
SL550194 |
RKO human intestine carcinoma cell line dual-labeled with luciferase and GFP, 2×10^6 cells |
1 vial |
Detail
|
Inquire |
SL550181 |
HEK293T cells stably expressing human ACE2 (NM_021804.2) and TMPRSS2(NM_005656.3), 2×10^6 cells |
1 vial |
Detail
|
Inquire |
SL550183 |
Human skin fibroblasts stably expressing SV40 large T antigen, 2×10^6 cells |
1 vial |
Detail
|
Inquire |
SL550187 |
Human adipose-derived mesenchymal stem cell line stably expressing SV40 large T antigen, 2×10^6 cells |
1 vial |
Detail
|
Inquire |
SL550191 |
HepG2 cell line dual-labeled with luciferase and GFP, 2×10^6 cells |
1 vial |
Detail
|
Inquire |
SL550182 |
Human gall bladder epithelial cell stably expressing SV40 large T antigen, 2×10^6 cells |
1 vial |
Detail
|
Inquire |
SL550185 |
Human bone marrow-derived mesenchymal stem cell line stably expressing SV40 large T antigen, 2×10^6 cells |
1 vial |
Detail
|
Inquire |
SL550188 |
Human umbilical cord-derived mesenchymal stem cell line stably expressing SV40 large T antigen, 2×10^6 cells |
1 vial |
Detail
|
Inquire |
SL550189 |
Human umbilical cord-derived mesenchymal stem cell line stably expressing SV40 large T antigen and hTERT gene, 2×10^6 cells |
1 vial |
Detail
|
Inquire |
SL550190 |
Neuro-2a mouse neuroblastoma cell line dual-labeled with luciferase and GFP, 2×10^6 cells |
1 vial |
Detail
|
Inquire |
SL550186 |
Human bone marrow-derived mesenchymal stem cell stably expressing SV40 large T antigen and hTERT gene, 2×10^6 cells |
1 vial |
Detail
|
Inquire |
SL550201 |
GFP-labeled Panc 10.05 cancer cell line, 2×10^6 cells |
1 vial |
Detail
|
Inquire |
SL550204 |
GFP-labeled KATO III cancer cell line, 2×10^6 cells |
1 vial |
Detail
|
Inquire |
SL550208 |
HEK293/induced Cas9-AAVS1-hyg, single clone, 2×10^6 cells |
1 vial |
Detail
|
Inquire |
SL550215 |
HCT116/BRAF V600E Homozygote cell line, with spike-in, 2×10^6 cells |
1 vial |
Detail
|
Inquire |